vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and Principal Financial Group (PFG). Click either name above to swap in a different company.
Principal Financial Group is the larger business by last-quarter revenue ($4.6B vs $346.4M, roughly 13.2× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 11.3%, a 16.8% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs -3.7%). Over the past eight quarters, Principal Financial Group's revenue compounded faster (6.3% CAGR vs 1.5%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Principal Financial GroupPFGEarnings & Financial Report
Principal Financial Group, Inc. (PFG) is an American global financial investment management and insurance company headquartered in Des Moines, Iowa, United States.
HAE vs PFG — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $346.4M | $4.6B |
| Net Profit | $97.3M | $517.0M |
| Gross Margin | 57.2% | — |
| Operating Margin | 36.1% | — |
| Net Margin | 28.1% | 11.3% |
| Revenue YoY | 4.8% | -3.7% |
| Net Profit YoY | — | -42.9% |
| EPS (diluted) | — | $2.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $4.6B | ||
| Q3 25 | $327.3M | $3.7B | ||
| Q2 25 | $321.4M | $3.7B | ||
| Q1 25 | $330.6M | $3.7B | ||
| Q4 24 | $348.5M | $4.8B | ||
| Q3 24 | $345.5M | $3.0B | ||
| Q2 24 | $336.2M | $4.3B |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $517.0M | ||
| Q3 25 | $38.7M | $213.8M | ||
| Q2 25 | $34.0M | $406.2M | ||
| Q1 25 | $58.0M | $48.1M | ||
| Q4 24 | $37.5M | $905.4M | ||
| Q3 24 | $33.8M | $-220.0M | ||
| Q2 24 | $38.4M | $353.1M |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | 16.8% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 11.8% | — |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | 11.3% | ||
| Q3 25 | 11.8% | 5.8% | ||
| Q2 25 | 10.6% | 11.1% | ||
| Q1 25 | 17.5% | 1.3% | ||
| Q4 24 | 10.8% | 19.1% | ||
| Q3 24 | 9.8% | -7.3% | ||
| Q2 24 | 11.4% | 8.2% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $2.30 | ||
| Q3 25 | $0.81 | $0.95 | ||
| Q2 25 | $0.70 | $1.79 | ||
| Q1 25 | $1.17 | $0.21 | ||
| Q4 24 | $0.74 | $3.92 | ||
| Q3 24 | $0.66 | $-0.95 | ||
| Q2 24 | $0.74 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $4.4B |
| Total DebtLower is stronger | $1.2B | $3.9B |
| Stockholders' EquityBook value | $796.3M | $11.9B |
| Total Assets | $2.4B | $341.4B |
| Debt / EquityLower = less leverage | 1.53× | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $4.4B | ||
| Q3 25 | $296.4M | $5.1B | ||
| Q2 25 | $292.9M | $3.7B | ||
| Q1 25 | $306.8M | $3.9B | ||
| Q4 24 | $320.8M | $4.2B | ||
| Q3 24 | $299.3M | $6.2B | ||
| Q2 24 | $344.4M | $4.8B |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $3.9B | ||
| Q3 25 | $1.2B | $3.9B | ||
| Q2 25 | $1.2B | $3.9B | ||
| Q1 25 | $1.2B | $4.3B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.9B |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $11.9B | ||
| Q3 25 | $849.2M | $11.7B | ||
| Q2 25 | $882.3M | $11.4B | ||
| Q1 25 | $820.8M | $11.2B | ||
| Q4 24 | $906.9M | $11.1B | ||
| Q3 24 | $878.9M | $11.2B | ||
| Q2 24 | $905.4M | $11.0B |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $341.4B | ||
| Q3 25 | $2.4B | $334.5B | ||
| Q2 25 | $2.5B | $323.1B | ||
| Q1 25 | $2.5B | $313.0B | ||
| Q4 24 | $2.5B | $313.7B | ||
| Q3 24 | $2.5B | $322.9B | ||
| Q2 24 | $2.5B | $308.8B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | 0.33× | ||
| Q3 25 | 1.44× | 0.34× | ||
| Q2 25 | 1.39× | 0.34× | ||
| Q1 25 | 1.49× | 0.39× | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | $1.7B |
| Free Cash FlowOCF − Capex | $209.9M | — |
| FCF MarginFCF / Revenue | 60.6% | — |
| Capex IntensityCapex / Revenue | 9.5% | — |
| Cash ConversionOCF / Net Profit | 3.01× | 3.37× |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $1.7B | ||
| Q3 25 | $111.3M | $1.0B | ||
| Q2 25 | $17.4M | $811.9M | ||
| Q1 25 | $116.6M | $977.3M | ||
| Q4 24 | $43.8M | $1.5B | ||
| Q3 24 | $48.8M | $1.1B | ||
| Q2 24 | $-27.4M | $1.4B |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | — | ||
| Q3 25 | $106.3M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-33.1M | — |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | — | ||
| Q3 25 | 32.5% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | -9.8% | — |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 1.7% | — |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 3.37× | ||
| Q3 25 | 2.88× | 4.70× | ||
| Q2 25 | 0.51× | 2.00× | ||
| Q1 25 | 2.01× | 20.32× | ||
| Q4 24 | 1.17× | 1.61× | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | 4.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
PFG
| Segment Retirement And Income Solutions | $1.6B | 36% |
| Segment Benefits And Protection | $1.1B | 23% |
| Other | $582.8M | 13% |
| Segment Principal Asset Management | $465.6M | 10% |
| Subsegment Investment Management | $449.4M | 10% |
| Administrative Service | $152.2M | 3% |
| Subsegment International Pension | $91.2M | 2% |
| Segment Corporate | $73.0M | 2% |
| Subsegment Life Insurance | $26.1M | 1% |
| Financial Service Other | $25.1M | 1% |
| Residential Mortgage | $7.4M | 0% |
| Subsegment Specialty Benefits | $3.7M | 0% |
| Deposit Account | $3.4M | 0% |
| Commission Income | $1.8M | 0% |
